美洲大蠊抗菌肽AMPPA13的表达及纯化

[目的]预测美洲大蠊新的抗菌肽基因,构建原核表达体系并纯化表达产物。[方法]通过生物信息学方法,预测分析出潜在的美洲大蠊抗菌肽。构建pET32a重组质粒,优化诱导表达条件,通过亲和层析,分子筛等手段获得纯化的抗菌肽,并进行Western Blot鉴定。[结果]预测出美洲大蠊新的抗菌肽基因AMPPA13,成功构建重组质粒pET32aAMPPA13。优化诱导表达条件得最佳IPTG浓度为0.1 mmol/L,最佳诱导时间为4 h,最佳诱导温度为37℃。纯化后AMPPA13浓度为268μg/m L。[结论]克隆出美洲大蠊抗菌肽基因,并成功构建原核表达体系,得到1 m L纯化的AMPPA13,经Western Blot鉴定,表达产物正确。     

美洲大蠊Per a7基因的克隆、表达及免疫学鉴定

根据原肌球蛋白基因序列设计引物,以我国南方地区美洲大蠊Periplaneta Americana RNA为模板,用RT-PCR方法扩增出852 bp的全长编码片段,经序列分析发现该基因与NCBI公布的Per a7有3个核苷酸发生改变。将目的片段克隆到pET24a(+)表达载体中,在大肠杆菌BL21 Star获得表达,融合蛋白的分子量约为33 kD。利用蟑螂过敏性患者血清对表达产物进行Western blotting检测,出现明显的识别条带,说明表达产物具有IgE结合活性。     

脱氧鬼臼毒素对美洲大蠊乙酰胆碱受体信号通路分子mRNA表达水平的影响

【目的】探讨脱氧鬼臼毒素(deoxyopodophyllotoxin, DOP)对美洲大蠊Periplaneta americana神经系统乙酰胆碱受体信号通路的影响。【方法】从美洲大蠊头部克隆乙酰胆碱受体信号通路上的关键信号分子nAChR α6亚基、 CaM和 CaMKⅡ的部分mRNA, 并测定其序列。应用荧光定量PCR技术分别观察注射不同浓度（10, 45, 80, 115和150 μg/μL） DOP 24和48 h后上述3种基因表达水平的变化。【结果】测序结果显示, 克隆出的美洲大蠊nAChR基因部分序列（539 bp）与赤拟谷盗Tribolium castaneum nAChR α6亚基基因的核苷酸序列一致性为84%; 美洲大蠊CaM基因（435 bp）与雕叶蝉Graphocephala atropunctata CaM基因的核苷酸序列一致性为85%; 美洲大蠊CaMKⅡ基因（513 bp）与黑腹果蝇Drosophila melanogaster CaMKⅡ基因的核苷酸一致性为77%。实时定量荧光PCR实验表明： DOP处理48 h后对美洲大蠊nAChR α6亚基、 CaM和CaMKII基因表达水平大体表现出低剂量激活, 高剂量抑制的特点。45~80 μg/μL DOP浓度范围内3种基因表达水平达到高峰, 80~150 μg/μL 浓度范围内表现为抑制作用, 基因表达水平呈下降趋势。【结论】DOP需要在美洲大蠊体内蓄积一定时间才有明显的作用, 能与nAChR结合引起CaM-CaMKⅡ级联反应, 使3种基因的表达在低浓度组上调、 高浓度组被抑制, 进而对美洲大蠊产生潜在的毒杀作用。     

花生主要变应原Ara h2的克隆及原核表达

目的:在原核载体中克隆、表达花生主要变应原Ara h2,为其重组变应原应用研究奠定基础。方法:合成花生主要变应原Ara h2基因,设计特异性引物行PCR扩增,经Eco RⅠ、HindⅢ双酶切后与做相应酶切的pET-28a载体连接,转化大肠杆菌BL21,提取质粒进行双酶切鉴定及测序分析,使用IPTG诱导融合蛋白表达,使用Ara h2特异性多克隆抗体对表达产物进行免疫印迹鉴定。结果:成功扩增了Ara h2基因,重组质粒双酶切见目的条带,基因测序显示Ara h2在正确开放阅读框中,基因长423bp,编码140个氨基酸,预测的等电点为5.3,分子量约16660.17 Da,基因比对分析显示其与相关报道的核苷酸序列一致性达100%。重组pET-28a-Ara h2/BL21经0.6 mmol/L IPTG诱导表达可见重组融合蛋白在相应分子量大量表达,使用Ara h2多克隆抗体免疫印迹法能检测到目的蛋白。结论:成功克隆、表达了花生主要变应原Ara h2,为其重组变应原应用研究奠定了基础。     

美洲大蠊主要变应原蛋白的质谱鉴定与分析

为了建立美洲大蠊Periplaneta americana变应原蛋白的质谱鉴定方法,我们将美洲大蠊粗浸液通过DEAE-52离子交换层析、Sephacryl S-200凝胶过滤层析等分离步骤得到纯化的74 kD蛋白,对纯化前后的该74 kD蛋白分别进行SDS-PAGE及凝胶内胰酶酶切,再经液相色谱-电喷雾-串联质谱（HPLC-ESI-MS/MS）在线联机分析,所得质谱数据进入网站（http://www.matrixscience.com）进行Mascot检索比对。通过对两者质谱鉴定结果的比较来评估美洲大蠊天然主要变应原蛋白的纯化效果。结果表明,纯化蛋白经HPLC-ESI-MS/MS鉴定是美洲大蠊主要变应原蛋白;离子交换层析等纯化步骤可以去除同一分子量的杂蛋白(如卵黄原蛋白),从而获得较好的鉴定结果。我们首次成功地运用质谱建立起变应原蛋白的新鉴定方法。     

尘螨变应原Derf1真核表达载体的构建及转染CHO细胞

目的：构建尘螨变应原Der f1真核表达载体,转染真核细胞并进行蛋白表达。方法：根据Genebank中Der f1基因的核酸序列（AB034946）,设计引物,采用PCR法,从保存的JM109工程菌中扩增Der f1编码基因,克隆到真核表达质粒pcDNA3.1/myc-his A上,以脂质体法转染CHO细胞,经G418筛选,进行稳定表达细胞株的筛选和鉴定。结果：将目的基因Der f1成功连接到pcDNA3.1/myc-hisA-Derf1并转染CHO细胞,获得稳定表达的CHO细胞株。结论：成功构建了尘螨变应原Der f1真核表达载体,并转染CHO细胞表达蛋白质。     

美洲大蠊3-磷酸甘油醛脱氢酶基因的克隆及表达

旨在通过5’-RACE获得美洲大蠊3-磷酸甘油醛脱氢酶(GAPDH)基因的全长cDNA序列,进行生物信息学分析,构建原核表达载体,诱导重组蛋白表达,为进一步研究其功能奠定基础.通过3’-RACE技术,PCR扩增获取编码美洲大蠊GAPDH蛋白的全长cDNA序列;采用生物信息学方法推导出该序列编码的氨基酸序列及其理化性质;预测信号肽、蛋白疏水性、可溶性、跨膜区结构、二级结构、三级结构,并构建系统发育树;构建原核表达载体pET28a-GAPDH,IPTG诱导重组蛋白表达,并用Histag抗体Western blotting验证.结果显示,美洲大蠊GAPDH基因,其完整阅读框含999个碱基,编码332个氨基酸.序列分析显示,该蛋白与家蚕GAPDH相似性为89％,具有GAPDH保守功能域,经IPTG诱导获得重组蛋白.     

黑胸大蠊浓核病毒NS2蛋白的表达、抗体制备及亚细胞定位

ns2是黑胸大蠊浓核病毒的一个非结构基因, 所编码的蛋白质大小为30 kD, 是一个功能未知的基因。为了对该基因进行深入的功能研究, 从感染了黑胸大蠊浓核病毒的蟑螂的后肠组织中通过RT-PCR得到ns2基因编码序列, 将其构建于原核表达载体pET-28a, 转化大肠杆菌BL21(DE3) 获得融合表达产物。此融合蛋白经分离纯化后, 免疫新西兰大白兔, 制备其多克隆抗体。采用Western印迹技术, 用该抗体检测ns2基因的真核表达产物, 证明该抗体有较好的针对NS2蛋白的专一性, 可用于对NS2结构和功能的研究。同时, 将此编码序列克隆至果蝇细胞表达载体pAC, 得到重组质粒后转染果蝇S2细胞表达重组蛋白, 通过共聚焦显微镜用该抗体检测该蛋白在S2细胞中的亚细胞定位, 发现NS2蛋白主要定位于细胞质, 核内仅有少量分布。     

尘螨变应原Der f1 真核表达载体的构建及转染CHO 细胞

目的:构建尘螨变应原Der f1真核表达载体,转染真核细胞并进行蛋白表达.方法:根据Genebank中Der f1基因的核酸序列(AB034946),设计引物,采用PCR法,从保存的JM109工程菌中扩增Der f1编码基因,克隆到真核表达质粒pcDNA3.1/myc-hisA上,以脂质体法转染CHO细胞,经G418筛选,进行稳定表达细胞株的筛选和鉴定.结果:将目的基因Der f1成功连接到pcDNA3.1/myc-hisA-Derf1并转染CHO细胞,获得稳定表达的CHO细胞株.结论:成功构建了尘螨变应原Der f1真核表达载体,并转染CHO细胞表达蛋白质.     

基于转录组测序分析美洲大蠊提取物促进小鼠创面愈合的分子机制

美洲大蠊Periplaneta americana是传统的中药材,其提取物已在临床上广泛用于创面治疗,但对其中的分子机制知之甚少。本文通过构建小鼠皮肤创伤模型,并基于转录组测序(RNA-seq)深入分析美洲大蠊提取物促进小鼠创面愈合的分子机制。首先构建C57小鼠皮肤全层切除模型,并将其分为3组,其中实验组分别以2种美洲大蠊提取物(康复新液、精粉)为敷料,而对照组以75%乙醇为敷料。用药处理3 d后取伤口皮肤组织送样进行RNAseq,然后分析转录组数据找出与伤口愈合相关的差异性表达基因,并利用荧光定量PCR(Q-PCR)对伤口组织中相关基因的表达量进一步验证。实验结果显示,实验组小鼠伤口的结痂速度比对照组快,这表明了小鼠创面模型中,美洲大蠊提取物能促进伤口愈合。经转录组分析,得到显著性差异表达基因数:对照组vs.精粉组为545,对照组vs.康复新液组为938。结合生物信息分析结果和已发表的文献,发现3个可能参与调节伤口愈合的关键基因:表皮调节素(Ereg)、Gli-kruppel家族成员(Gli2)和表皮型转谷氨酰胺酶3(Tgm3)。Q-PCR实验表明,这3个基因在美洲大蠊提取物加药组中均高表达。本文研究结果表明,2种美洲大蠊提取物:康复新液、精粉可能通过诱导Ereg、Tgm3和Gli2的高表达来促进皮肤创面的愈合。     

Expression, purification, and immunological characterization of Cr PI

An efficient preparation of Periplaneta americana nymphae allergen, Cr PI (54 kDa) is described. It was expressed as a GST-tag fusion protein in Escherichia coli, strain BL21 (DE3). Expression of recombinant Cr PI (rCr PI), denaturation/renaturation of the inclusion bodies and the effects of protein and L-arginine concentration on inclusion body aggregation were optimized. The fusion protein was purified by affinity chromatography and size exclusion chromatography, and Cr PI fusion protein was purified to >95%. rCr PI bound strongly to IgE in the sera of individuals with cockroach allergies as shown by western blot and ELISA. Highly refolded and purified recombinant protein was obtained, providing a basis for the large-scale preparation of Cr PI allergen.     

Sequence analysis of the first complete cDNA clone encoding an American cockroach Per a 1 allergen

C3, designated as Per a 1.0103 according to WHO/IUIS nomenclature, encoding a novel American cockroach allergen of 395 aa (44.6 kDa), is the first complete cDNA clone with a translatable immunoreactive protein among the reported group 1 cockroach allergens. Its deduced amino acid sequence possesses a signal sequence, phosphorylation sites, mitochondrial energy transfer protein signatures, and four repeats each sharing striking similarity with the corresponding repeats of the other cockroach allergens. The latter similarity suggests that the group 1 cockroach allergens might have evolved from a primordial mitochondrial sequence by exon duplication.     

Molecular characterization of American cockroach tropomyosin (Periplaneta americana allergen 7), a cross-reactive allergen

Inhalation of allergens produced by the American cockroach (Periplaneta americana) induces IgE Ab production and the development of asthma in genetically predisposed individuals. The cloning and expression in Escherichia coli of P. americana tropomyosin allergen have been achieved. The protein shares high homology with other arthropod tropomyosins (80% identity) but less homology with vertebrate ones (50% identity). The recombinant allergen was produced in E. coli as a nonfusion protein with a yield of 9 mg/l of bacterial culture. Both natural and recombinant tropomyosins were purified by isoelectric precipitation. P. americana allergen 1 (Per a 1) and Per a 7 (tropomyosin) are to date the only cross-reacting allergens found in cockroaches. ELISA and Western blot inhibition experiments, using natural and recombinant purified tropomyosins from shrimp and cockroach, showed that tropomyosin induced cross-reactivity of IgE from patients allergic to these allergens, suggesting that this molecule could be a common allergen among invertebrates.     

尘螨变应原Der f 1核酸序列测定及其分子进化分析

目的：对尘螨主要变应原Der f 1进行核酸序列测定,探讨其系统进化信息。方法：根据Genbank公布的Der f 1基因序列设计引物,巢式PCR扩增Der f 1的cDNA,纯化、回收、克隆至pMD19-T simple后进行序列测定,序列比对后用Clustal W1.83构建分子进化树。结果：成功扩增出Der f 1的cDNA片段,测序表明该基因含ORF1个,长度966bp,与参考序列同源性达99．9％。该变应原具半胱氨酸蛋白酶活性,与果蝇进化关系最远,与梅氏嗜霉螨进化关系最近。结论：成功获得了尘螨变应原Der f 1基因片段．根据其编码的氨基酸序列构建出的系统进化树与形态学分类不一致。     

尘螨变应原Derf1核酸序列测定及其分子进化分析

目的:对尘螨主要变应原Der f1进行核酸序列测定,探讨其系统进化信息。方法:根据Genbank公布的Der f1基因序列设计引物,巢式PCR扩增Der f1的cDNA,纯化、回收、克隆至pMD19-T simple后进行序列测定,序列比对后用Clustal W 1.83构建分子进化树。结果:成功扩增出Der f1的cDNA片段,测序表明该基因含ORF1个,长度966bp,与参考序列同源性达99.9%。该变应原具半胱氨酸蛋白酶活性,与果蝇进化关系最远,与梅氏嗜霉螨进化关系最近。结论:成功获得了尘螨变应原Der f1基因片段,根据其编码的氨基酸序列构建出的系统进化树与形态学分类不一致。     

Proteome mining for novel IgE-binding proteins from the German cockroach (Blattella germanica) and allergen profiling of patients

Although cockroaches are known to produce allergens that can cause IgE-mediated hypersensitivity reactions, including perennial rhinitis and asthma, the various cockroach allergens have not yet been fully studied. Many proteins from the German cockroach show high IgE reactivity, but have never been comprehensively characterized. To identify these potential allergens, proteins were separated by 2-DE and IgE-binding proteins were analyzed by nanoLC-MS/MS or N-terminal sequencing analysis. Using a combination of proteomic techniques and bioinformatic allergen database analysis, we identified a total of ten new B. germanica IgE-binding proteins. Of these, aldolase, arginine kinase, enolase, Hsp70, triosephosphate isomerase, and vitellogenin have been reported as allergens in species other than B. germanica. Analysis of the Food Allergy Research and Resource Program allergen database indicated that arginine kinase, enolase, and triosephosphate isomerase showed significant potential cross-reactivity with other related allergens. This study revealed that vitellogenin is an important novel B. germanica allergen. Personalized profiling and reactivity of IgE Abs against the panel of IgE-binding proteins varied between cockroach-allergic individuals. These findings make it possible to monitor the individual IgE reactivity profile of each patient and facilitate personalized immunotherapies for German cockroach allergy disorders.     

Treatment with Pyranopyran-1, 8-Dione Attenuates Airway Responses in Cockroach Allergen Sensitized Asthma in Mice

Chronic allergic asthma is characterized by Th2-typed inflammation, and contributes to airway remodeling and the deterioration of lung function. Viticis Fructus (VF) has long been used in China and Korea as a traditional herbal remedy for treating various inflammatory diseases. Previously, we have isolated a novel phytochemical, pyranopyran-1, 8-dione (PPY), from VF. This study was conducted to evaluate the ability of PPY to prevent airway inflammation and to attenuate airway responses in a cockroach allergen-induced asthma model in mice. The mice sensitized to and challenged with cockroach allergen were treated with oral administration of PPY. The infiltration of total cells, eosinophils and lymphocytes into the BAL fluid was significantly inhibited in cockroach allergen-induced asthma mice treated with PPY (1, 2, or 10 mg/kg). Th2 cytokines and chemokine, such as IL-4, IL-5, IL-13 and eotaxin in BAL fluid were also reduced to normal levels following treatment with PPY. In addition, the levels of IgE were also markedly suppressed after PPY treatment. Histopathological examination demonstrated that PPY substantially inhibited eosinophil infiltration into the airway, goblet cell hyperplasia and smooth muscle hypertrophy. Taken together, these results demonstrate that PPY possesses a potent efficacy on controlling allergic asthma response such as airway inflammation and remodeling.     

Cloning of cDNA encoding a soybean allergen, Gly m Bd 28K

A cDNA clone encoding a soybean allergen, Gly m Bd 28K, has been isolated. The clone has a 1567-bp cDNA insert with a 1419-bp open reading frame and a 148-bp 3'-untranslated region, followed by a polyadenylation tail. The open reading frame was shown to encode a polypeptide composed of 473 amino acids. The chemically determined amino acid sequences of the peptides obtained from the allergen, including its N-terminal peptide, were shown to be contained in the N-terminal region of the amino acid sequence deduced from the cDNA, showing that the first half of the cDNA encodes the allergen with a preceding segment of 21 amino acids. The peptide fragment including the allergen was expressed as a fusion protein with glutathione S-transferase in Escherichia coli and immunoblotted with the sera of soybean-sensitive patients and the monoclonal antibody against the allergen. Furthermore, homology analyses demonstrate that the polypeptide for the cDNA exhibits high homology with the MP27/MP32 proteins in pumpkin seeds and the carrot globulin-like protein. This finding suggests that the polypeptide may consist of a 21-amino acid segment as a part of the signal peptide and the proprotein, which may be converted to two mature proteins, Gly m Bd 28K and a 23-kDa protein, during the development of soybean cotyledons.     

Prevention and reversal of pulmonary inflammation and airway hyperresponsiveness by dexamethasone treatment in a murine model of asthma induced by house dust

The morbidity and mortality from asthma in the Western world have increased 75% in the past 20 years. Recent studies have demonstrated that sensitization to cockroach allergens correlates strongly with the increased asthma morbidity for adults and children. We investigated whether dexamethasone administered before or after allergen challenge would inhibit the pulmonary inflammation and airway hyperresponsiveness in a mouse model of asthma induced by a house dust extract with high levels of cockroach allergens. For the prevention experiment, mice were treated with an intraperitoneal injection of dexamethasone 1 h before each pulmonary challenge, and airway hyperresponsiveness was measured 24 h after the last challenge. Mice were killed 48 h after the last challenge. For the reversal study, airway hyperresponsiveness was measured 24 h after the last challenge, and the mice were treated with dexamethasone. Dexamethasone treatment before allergen challenge significantly reduced the pulmonary recruitment of inflammatory cells, myeloperoxidase activity in the lung, airway hyperreactivity, and total serum IgE levels compared with PBS-treated mice. Additionally, dexamethasone treatment could significantly reduce the airway hyperreactivity of an established asthmatic response. These results demonstrate that dexamethasone not only prevents but also halts the asthmatic response induced by house dust containing cockroach allergens. This model exhibits several features of human asthma that may be exploited in the study of pathophysiological mechanisms and potential therapeutic interventions.